CTI BioPharma Corp (CTIC) Down 1.77% in Premarket Trading

Monday, April 18, 2022 08:22 AM | InvestorsObserver Analysts

Mentioned in this article

CTI BioPharma Corp (CTIC) Down 1.77% in Premarket Trading

CTI BioPharma Corp (CTIC) has fallen Monday morning, with the stock decreasing -1.77% in pre-market trading to 4.44. CTIC's short-term technical score of 89 indicates that the stock has traded more bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, the stock ranks higher than 97% of stocks. CTI BioPharma Corp has risen 8.13% over the past month, closing at $4.08 on March 21. During this period of time, the stock fell as low as $4.08 and as high as $5.25. CTIC has an average analyst recommendation of Strong Buy. The company has an average price target of $7.35.

CTIC has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on CTIC!

See Full CTIC Report

CTI BioPharma Corp has a Long-Term Technical rank of 98. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 2% of the market scoring higher. In the Biotechnology industry which is number 127 by this metric, CTIC ranks better than 100% of stocks.

Important Dates for Investors in CTIC:

-CTI BioPharma Corp is set to release earnings on 6/7/2022. Over the last 12 months, the company has reported EPS of $-1.09. -We do not have a set dividend date for CTI BioPharma Corp at this time. Click Here To Get The Full Report on CTI BioPharma Corp (CTIC)